
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
[ Fri, Aug 05th 2022 ]: WOPRAI
Gena Wang Upgraded (BLUE) to Hold and Increased Target to $5 on, Aug 5th, 2022


🞛 This publication is a summary or evaluation of another publication
Gena Wang of Barclays, Upgraded "bluebird bio, Inc." (BLUE) to Hold and Increased Target from $3 to $5 on, Aug 5th, 2022.
Gena has made no other calls on BLUE in the last 4 months.
There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 2 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Yaron Werber of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, April 6th, 2022
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 6th, 2022
These are the ratings of the 3 analyists that currently disagree with Gena
- Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $8 on, Tuesday, August 2nd, 2022
- Salveen Richter of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $2 on, Tuesday, May 24th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 17th, 2022